Kaiser Family Foundation/ Harvard School of Public Health Medicare Prescription Drug Survey
A new survey by the Kaiser Family Foundation and Harvard School of Public Health examines public opinion on the current Medicare prescription drug debate.
View the Latest: Prescription Drugs
Filter
-
-
Chartpack: Seniors’ Early Experiences With Their New Medicare Drug Plans – June 2006
Poll FindingChartpack: Seniors' Early Experiences With Their New Medicare Drug Plans - June 2006 These charts highlight key data from the June 2006 tracking poll on seniors' early enrollment experiences with the Medicare drug benefit. Chartpack (.
-
The New Medicare Rx Benefit: Challenges for Maintaining Access to Prescription Drugs
Other PostThe New Medicare Rx Benefit: Challenges for Maintaining Access to Prescription Drugs With the launch of the new Medicare Part D prescription drug benefit less than 18 months away, and growing interest in beneficiaries’ access to medications in the future, the Kaiser Family Foundation is pleased to release two new publications that examine issues concerning…
-
Political History of Medicare and Prescription Drug Coverage
Other PostA Political History of Medicare and Prescription Drug Coverage Thomas R. Oliver, Philip R. Lee, and Helene L. Lipton This article examines the history of efforts to add prescription drug coverage to the Medicare program. It identifies several important patterns in policymaking over four decades.
-
Toplines: National Survey of Physicians, Findings on Medicare Part D
Poll FindingThese toplines provide the results of a 2006 national survey of physicians on their views and experiences related to the new Medicare drug benefit. Topline (.
-
The Medicare Prescription Drug Law – What Are Seniors Saying?
Other PostAs the first phase of the new Medicare prescription drug law takes effect, the Kaiser Family Foundation commissioned focus groups conducted by Bill McInturff of Public Opinion Strategies and Geoff Garin of Peter D. Hart Research Associates in consultation with Foundation staff.
-
Reactions to the New Medicare Law, Findings Based on Focus Groups with People on Medicare
ReportThis report, Reactions to the New Medicare Drug Law, produced jointly by a bipartisan team of pollsters from Public Opinion Strategies and Peter D. Hart Research Associates, presents key findings from ten focus groups of people on Medicare in three cities: Pittsburgh, PA; Kansas City, KS, and Washington, DC.
-
Analyzing Options to Cover Prescription Drugs For Medicare Beneficiaries
ReportThis report examines the implications for Medicare beneficiaries of leading approaches to provide coverage for prescription drugs, looking at coverage, benefit levels and out-of-pocket spending.
-
USA Today/Kaiser Family Foundation/Harvard School of Public Health Survey: The Public on Prescription Drugs and Pharmaceutical Companies: Summary and Charts
Poll FindingThis document provides key findings from a USA Today/Kaiser/Harvard survey examining Americans’ views on, and experiences with, prescription drugs and the pharmaceutical industry, including drug costs, advertisements, safety issues, government regulation and medical research. Summary and Charts (.
-
Dual Eligibles in Nursing Facilities and Medicare Drug Coverage
Issue BriefThis Briefing Note explores the issues presented for the design and administration of a new Medicare drug benefit by dually eligible nursing facility residents. Issue Paper (.